ASKA Pharmaceutical Holdings Co (TSE:4886) Accounts Payable & Accrued Expense : 円6,338 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Accounts Payable & Accrued Expense?

ASKA Pharmaceutical Holdings Co's quarterly accounts payable & accrued expense increased from Jun. 2023 (円4,843 Mil) to Sep. 2023 (円5,368 Mil) and increased from Sep. 2023 (円5,368 Mil) to Dec. 2023 (円6,338 Mil).

ASKA Pharmaceutical Holdings Co's annual accounts payable & accrued expense declined from Mar. 2022 (円7,985 Mil) to Mar. 2023 (円7,785 Mil) but then increased from Mar. 2023 (円7,785 Mil) to Mar. 2024 (円12,750 Mil).

ASKA Pharmaceutical Holdings Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Accounts Payable & Accrued Expense Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

7,985.00

7,785.00

12,750.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							7,785.00	4,843.00	5,368.00	6,338.00	12,750.00

ASKA Pharmaceutical Holdings Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines